escalated-dose BEACOPP
E1409958
UNEXPLORED
Escalated-dose BEACOPP is an intensified chemotherapy regimen used primarily for treating advanced-stage Hodgkin lymphoma, featuring higher doses of the standard BEACOPP drug combination to improve disease control.
All labels observed (1)
| Label | Occurrences |
|---|---|
| escalated-dose BEACOPP canonical | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T20061766 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: escalated-dose BEACOPP Context triple: [BEACOPP regimen, hasVariant, escalated-dose BEACOPP]
-
A.
standard BEACOPP
Standard BEACOPP is an intensive multi-drug chemotherapy regimen primarily used to treat advanced-stage Hodgkin lymphoma.
-
B.
BEACOPP regimen
The BEACOPP regimen is an intensive multi-drug chemotherapy protocol used primarily for advanced-stage Hodgkin lymphoma.
-
C.
R-CHOP
R-CHOP is a standard chemotherapy regimen combining rituximab with multiple cytotoxic drugs, commonly used to treat non-Hodgkin lymphoma.
-
D.
ABVD regimen
The ABVD regimen is a standard chemotherapy combination used as first-line treatment for classical Hodgkin lymphoma.
-
E.
MOPP chemotherapy regimen
The MOPP chemotherapy regimen is an early combination cancer treatment protocol, historically used for Hodgkin lymphoma, that includes multiple cytotoxic drugs administered in cycles.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: escalated-dose BEACOPP Target entity description: Escalated-dose BEACOPP is an intensified chemotherapy regimen used primarily for treating advanced-stage Hodgkin lymphoma, featuring higher doses of the standard BEACOPP drug combination to improve disease control.
-
A.
standard BEACOPP
Standard BEACOPP is an intensive multi-drug chemotherapy regimen primarily used to treat advanced-stage Hodgkin lymphoma.
-
B.
BEACOPP regimen
The BEACOPP regimen is an intensive multi-drug chemotherapy protocol used primarily for advanced-stage Hodgkin lymphoma.
-
C.
R-CHOP
R-CHOP is a standard chemotherapy regimen combining rituximab with multiple cytotoxic drugs, commonly used to treat non-Hodgkin lymphoma.
-
D.
ABVD regimen
The ABVD regimen is a standard chemotherapy combination used as first-line treatment for classical Hodgkin lymphoma.
-
E.
MOPP chemotherapy regimen
The MOPP chemotherapy regimen is an early combination cancer treatment protocol, historically used for Hodgkin lymphoma, that includes multiple cytotoxic drugs administered in cycles.
- F. None of above. chosen
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.